Heron Therapeutics
HRTX
#10254
Rank
A$77.86 M
Marketcap
A$0.41
Share price
-3.26%
Change (1 day)
-76.22%
Change (1 year)

EPS for Heron Therapeutics (HRTX)

EPS in 2026 (TTM): A-$0.28

According to Heron Therapeutics's latest financial reports the company's current EPS (TTM) is A-$0.28. In 2025 the company made an earnings per share (EPS) of A-$0.18 a decrease over its 2024 EPS that were of A-$0.13.

EPS history for Heron Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.2856.95%
2025A-$0.1833.33%
2024A-$0.13
2022A-$2.59-23.11%
2021A-$3.37-10%
2020A-$3.75-0%
2019A-$3.751.21%
2018A-$3.70
2016A-$6.8254.76%
2015A-$4.411.73%
2014A-$4.33-16.23%
2013A-$5.1791.67%
2012A-$2.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
SurModics
SRDX
A-$1.84 547.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Pacira Biosciences
PCRX
A$0.52-284.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$3.88-1,463.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A-$0.0000000000-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Nektar Therapeutics
NKTR
A-$10.04 3,426.32%๐Ÿ‡บ๐Ÿ‡ธ USA